| Rosa Elvira Leon, | |
|
5151 E Broadway Blvd Ste 1500, Tucson, AZ 85711-3787 | |
| (906) 420-1128 | |
| Not Available |
| Full Name | Rosa Elvira Leon |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5151 E Broadway Blvd Ste 1500, Tucson, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023891413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosa Elvira Leon, 8237 E 3rd Pl, Tucson, AZ 85710-2549 Ph: () - | Rosa Elvira Leon, 5151 E Broadway Blvd Ste 1500, Tucson, AZ 85711-3787 Ph: (906) 420-1128 |
News Archive
New research led by the University of Birmingham suggests that skin cancer patients could have a better prognosis if their T cells send messages from five specific genes in their immune response to drugs given to treat the disease.
High-density lipoprotein (HDL) is often referred to as good cholesterol: high levels of HDL are associated with lower risk of cardiovascular disease. But many clinical outcome trials for drugs that raise HDL levels have failed to show significant benefits for trial participants.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
Microvesicles are smallest cell elements which are present in all body fluids and are different, depending on whether a person is healthy or sick. This could contribute to detecting numerous diseases, such as, e.g., carcinomas, at an early stage, and to treating them more efficiently. The problem is that the diameter of the relevant microvesicles generally lies below 100 nm, which makes them technically detectable, but their exact size and concentration hardly possible to determine. A new device is now to provide the metrological basis for these promising biomarkers.
Mayo Clinic researchers have shown why, in a minority of HIV patients, immune function improves despite a lack of response to standard anti-retroviral treatment. In these cases, researchers say, the virus has lost its ability to kill immune cells. The findings appear in the online journal PLoS Pathogens.
› Verified 6 days ago
Teresa Ramona Karjalainen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 720-404-0816 | |
Ashley Rae Holten, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2002 S Kelvin Stra, Tucson, AZ 85713 Phone: 719-304-1256 | |
Michael Cauble, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 6231 N Montebella Rd, Tucson, AZ 85704 Phone: 520-500-8348 | |
Mrs. Susan L. Johnson Lucht, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Danielle Marie Stradling, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 916-220-0518 | |
Graciela Contreras, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 E 10th St, Tucson, AZ 85719 Phone: 520-225-6000 | |
Gail Abbey, O.T. Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2500 N Rosemont Blvd, Tucson, AZ 85712 Phone: 520-325-4800 |